/
/
/

Vivanza Biosciences Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)1.88
Volume (₹)17,681.00
High (₹)1.90
Upper Circuit2.25
Low (₹)1.88
Lower Circuit1.51
Prev Close1.88
52W High (₹)2.72
Price1.89
52W Low (₹)1.52

Share Market Cap & Key Ratios Overview

M.Cap (₹)7.52 Cr
Div. Yield (%)0.00
PE Ratio16.56
Debt to Equity2.34
Price to Book1.62
Book Value1.09
EPS (TTM)0.11
Face Value1.00
ROE (%)9.48

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
AEGISLOG-ANSE
CPPLUS-ANSE
PREMIERENE-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
BLACKROSE-TNSE
VIVANZA-XNSE
LTP
1W Low
1W High
Market cap (₹)
3057.1+118.1 (4.02%)
2917.70
3141.40
4,19,654Cr
1353.1+99.6 (7.95%)
1235
1384
45,862Cr
3828.1+73.95 (1.97%)
3663.70
3900
45,287Cr
974.55-14.95 (-1.51%)
950
1004.95
44,033Cr
393.65+15.75 (4.17%)
369.55
403.55
30,661Cr
471.5+3.05 (0.65%)
464.95
483.50
15,489Cr
69.79-2.49 (-3.44%)
67.60
74.97
10,686Cr
333-5.9 (-1.74%)
332
345
7,647Cr
515.15-1.9 (-0.37%)
498.95
535
6,437Cr
111.9+1.1 (0.99%)
106.25
115.90
564Cr
1.89+0.16 (9.25%)
1.70
1.90
8Cr

Key Highlights of Vivanza Biosciences Ltd Balance Sheet

Vivanza Biosciences Ltd balance sheet discloses shareholders' funds of ₹4Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹4Cr, and the reserves and surplus of the company is ₹39.54Lakh.

The company has its non-current liabilities with total liabilities of ₹18.23Cr as of 2026-03-31.

The current liabilities are ₹12.95Cr as of 2026-03-31. At the same time, current assets are ₹15.59Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹1.91Cr and tangible assets of ₹12.31Lakh, provided in the Vivanza Biosciences Ltd financial statements.